Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons
- 1 August 1984
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 103 (3-4) , 269-278
- https://doi.org/10.1016/0014-2999(84)90487-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Naloxone blocks morphine enhancement of kainic acid neurotoxicityLife Sciences, 1982
- The effect of DSP-4 (N-[2-chloroethyl]-N-ethyl-2-bromobenzylamine) on monoamine oxidase activities in tissues of the ratJournal of Pharmacy and Pharmacology, 1981
- High-affinity [3H]DMI binding is associated with neuronal noradrenaline uptake in the periphery and the central nervous systemEuropean Journal of Pharmacology, 1981
- Amphetamine-induced inhibition of central noradrenergic neurons: A pharmacological analysisLife Sciences, 1979
- Inhibition of uptake of catecholamines by benzylamine derivativesJournal of Medicinal Chemistry, 1979
- Central Catecholamine Neuron Systems: Anatomy and Physiology of the Norepinephrine and Epinephrine SystemsAnnual Review of Neuroscience, 1979
- Liquid chromatographic analysis of catecholamines routine assay for regional brain mappingLife Sciences, 1976
- NORADRENALINE NERVE TERMINALS IN THE CEREBRAL CORTEX: EFFECTS ON NORADRENALINE UPTAKE AND STORAGE FOLLOWING AXONAL LESION WITH 6‐HYDROXYDOPAMINEJournal of Neurochemistry, 1974
- CHANGES IN THE DEVELOPMENT OF CENTRAL NOR ADRENALINE NEURONES FOLLOWING NEONATAL ADMINISTRATION OF 6‐HYDROXYDOPAMINE1Journal of Neurochemistry, 1974
- Effects of Amphetamine on Single Cell Activity in a Catecholamine Nucleus, the Locus CoeruleusNature, 1971